New Edge Advisors, LLC Meridian Bioscience Inc Transaction History

New Edge Advisors, LLC

  • $15 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$31.15 - $33.39 $67,626 - $72,489
2,171 New
2,171 $72,000
Q2 2022

Aug 09, 2022
SELL
$23.75 - $31.69 $587,955 - $784,517
-24,756 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$19.97 - $26.94 $494,377 - $666,926
24,756 New
24,756 $643,000

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email